- freely available
Int. J. Environ. Res. Public Health 2013, 10(12), 6687-6700; doi:10.3390/ijerph10126687
Published: 2 December 2013
Abstract: The aim of the study was the preparation of a liposome complex with encapsulated lead ions, which were electrochemically detected. In particular, experiments were focused on the potential of using an electrochemical method for the determination of free and liposome-encapsulated lead and determination of the encapsulation efficiency preventing the lead toxicity. Primarily, encapsulation of lead ions in liposomes and confirmation of successful encapsulation by electrochemical methods was done. Further, the reduction effect of the liposome matrix on the detected electrochemical signal was monitored. Besides encapsulation itself, comparison of toxicity of free lead ions and lead ions encapsulated in liposome was tested. The calculated IC50 values for evaluating the lead cytotoxicity showed significant differences between the lead enclosed in liposomes (28 µM) and free lead ions (237 µM). From the cytotoxicity studies on the bacterial strain of S. aureus it was observed that the free lead ions are less toxic in comparison with lead encapsulated in liposomes. Liposomes appear to be a suitable carrier of various substances through the inner cavity. Due to the liposome structure the lead enclosed in the liposome is more easily accepted into the cell structure and the toxicity of the enclosed lead is higher in comparison to free lead ions.
Lead is a heavy metal, toxic at extremely low doses and it has the acute and chronic effects on human health. It shows multi-system tissue toxicity, causing neurological, cardiovascular, renal, gastrointestinal, hematologic, reproductive, genotoxic and carcinogenic effects . Thanks to the negative characteristics of lead, it is necessary to monitor its amount in the body [2,3,4,5,6]. Moreover, some complexing agents could enhance or lower toxicity of this metal, thus the effects of such complexes should be considered. Liposomes are among such complexing agents. They are spherical nanoshells composed of lipid bilayers that enclose an aqueous phase. They are easily produced and stable in solution for a long time with no significant changes in size or structure . Due to their small and controllable size (from tens to thousands of nanometers) and the presence of internal cavities, liposomes are the most investigated organic nanoparticles . The internal cavity can be used for transporting enzymes, proteins, DNA, drugs and other substances [9,10,11]. Highly biocompatible liposomes can be modified by antibodies, protein receptors or radioactive substances [7,12,13]. Voltammetric methods can be used for characterization of the electroactive compounds in liposome cavity [14,15]. This study is focused on the application of electrochemical method for the determination of free and liposome-encapsulated lead and determination of the encapsulation efficiency preventing lead toxicity.
2. Results and Discussion
The first and basic step of the experiment was encapsulation of lead ions into the liposome cavity. Lead was chosen as a model substance because metals often form part of an electrochemical label. Examples of such systems are so called quantum dots, which are nanocrystals most often composed of metal sulphides or tellurides . Detailed sample preparation is described in the Experimental section and in Figure 1. The creation of this nanostructure was tested using electrochemical methods and atomic absorption spectrometry (AAS). Electrochemical techniques are one of the best methods for detecting metals due to their low cost, high sensitivity and potential portability [17,18,19,20,21]. Atomic absorption spectrometry was applied as a method for total lead determination. The verification of the encapsulation process was done by comparison of the amounts of lead determined by electrochemical methods and AAS. Because of the fact, that the electrochemical method is able to determine the lead on the surface of liposomes (and free in the solution) and on the contrary, AAS determines the total amount of lead (inside and outside of liposomes),the obtained difference should be thus related to the encapsulated lead amount.
2.1. Cyclic Voltammetry of Lead—Liposome Complex
A comparison of the signal changes of lead encapsulated in liposomes and a lead standard measured by CV is shown in Figure 2. With the increasing scan rate the lead signal increased (Figure 2A,B). It is clear from the results shown in Figure 2C that the change of the lead peak potential is not expressly influenced by scan rate. Lead standard signals and signals of lead in the liposomes are compared in Figure 2D. Lead concentrations in both samples were 20 µM. However, the signals of lead in liposomes were lower than the signals of samples containing lead standard only. Therefore, one may suggest that the liposome matrix reduces the detection of lead in the samples. Analytical outputs in Figure 2D are the slopes of linear dependence for lead standard y = 11.883x, R2 = 0.95 and lead in liposomes y = 7.897x, R2 = 0.94, which indicates that the slope for lead in liposomes is lower.
2.2. Lead Encapsulation in Liposome
Differential pulse voltammetry (DPV) was the second electrochemical method which was used for lead determination. The influence of the presence of liposomes (in measured lead solutions) on the obtained electrochemical signal was monitored (Figure 3A). It was seen that the lead peak height depended on the various lead concentrations (within the range from 1.25 to 20 µM) and compared to the signal intensity of free lead in the same concentration range. The resulting decrease in signal intensity is shown in Figure 3A. The average value of signal decrease is 61.8%. The obtained signals showed the change in peak potential too (Figure 3B). Peaks detected for free lead (lead nitrate standard solution) were located at −0.473 V, while the peaks related to the lead-liposome mixture were located approximately at −0.485 V. While the free lead determination peak potential was independent on the lead concentration, in the case of liposomes the peak potential was slightly dependent on the lead concentration (Figure 3B) - the growing lead concentration caused the potential shift to a more positive value.
For the investigation of liposome encapsulation efficiency the amount of lead in the liposomal fraction (created by dialysis) was monitored. Because lead is low molecular weight substance it is necessary to suggest that some part will be located on the surface of liposome structures. Therefore the amount of lead in the liposomal fraction was monitored by AAS to obtain maximum lead amount that could possibly be immobilized in this fraction (according to the original liposome concentration, see Experimental). The dependence of the amount of lead in the liposomal fraction related to the originally used amount of lead is presented in Figure 3C. It is obvious that the maximum amount of immobilized lead was about 170 µg. Because the difference between originally used lead amounts 300 and 400 g led to similar results, it should be assumed that the maximum amount of immobilized lead lies in the range from 152 to 170 µg.
The calculation of liposome encapsulation efficiency was based on the difference in the lead determination by AAS and DPV, as was mentioned above. The encapsulation efficiency was calculated in the concentration range of lead from 0.1 to 5 mM. The percentage of encapsulation efficiency related to the lead concentration is shown in Figure 3D. The calculated percentage was determined as the difference in the concentrations (obtained from above mentioned methods) and related to the originally used lead concentration. From the presented results it is obvious that the measured values of lead enclosed in liposomes were distinctly lower in comparison with the originally used lead concentrations. The efficiency of encapsulation decreased with increasing original lead concentration, as follows: y = −7.046x + 42.013, R2 = 0.97. This means that application of a lower original lead concentration led to a better result and, according to the previous paragraph, the application of an original lead concentration in the range from 0.1 to 2 mM is suitable. Since it was found that the application of lower original lead concentrations resulted in higher efficiency of the capture of lead ions in the liposomes, for sequent experiments µM concentrations of lead were chosen.
2.3. Toxicity Determination of Free Lead Ions and Lead Encapsulated in the Liposome
It is common knowledge that heavy metal ions cause inhibition of microorganism (bacterial) growth, therefore they are often incorporated into different kinds of materials to ensure antimicrobial activity [22,23]. The growth curves method serves as a tool to evaluate antimicrobial activity, as the effect of heavy metal ions on bacterial strains such as Staphylococcus aureus in this experiment [24,25,26]. It is possible to calculate the inhibition concentration value (IC50) from these curves via statistical methods . Eight different concentrations of lead ions (5, 10, 20, 50, 100, 150, 200 and 250 μM) free (Figure 4A,B) or encapsulated into liposome (Figure 4C,D) were added to the bacterial strain S. aureus in this experiment.
The application of heavy metal ions to S. aureus cells led to significant morphological changes, observed in the cells in terms of cell shapes and the cell wall thicknesses. The difference between control and S. aureus cells after lead ion application is presented in Figure 4A. The cell wall was considerably thickened and the presence of so called cross walls (septal midline) was observed. These inner transverse walls are formed due to the developing resistance. Similar phenomenon is commonly observed in the case of methicillin-resistant strains of S. aureus commonly called MRSA strains [28,29,30].
The growth curves of S. aureus treated with both lead variants (free lead ions and lead ions encapsulated in liposomes) are presented in Figure 4B,D. The growth was the most rapid in the first six hours of measurement; therefore the growth rate of each variant was compared to S. aureus control. The same evaluation was done after 24 h. This time period was chosen to represent the long-term effect of lead on S. aureus. The growth curves show that the lead ions both enclosed in liposomes and free had antimicrobial activity and this growth inhibition was more significant with the increasing lead ions concentration. The inhibition effect of individual lead concentrations and forms (free and encapsulated) are presented in Figure 4C,E. The presented growth rate inhibition was calculated as the percentage of difference between the growth rate of the S. aureus control and the individually treated variants related to the S. aureus control. Figure 4C presents results related to the system with free lead ions for 6 and 24 h. Presented results show that the long-term effect of free ions is lower about 16% on average compared to the short-term effect. The maximum inhibition effect was achieved for the concentration of 250 µM for both time periods; after 6 h there was a 64% and for 24 h a 51% inhibition effect. More rapid increase of the inhibition effect was observed with the variants of lead in liposomes (Figure 4E) compared to the variants without liposomes. Application of liposome encapsulation caused a reduction of the differences between the short and long-term effects. This difference was reduced to 8% on average. Free lead ion application produced a maximal inhibition in 6 h of 64% The same inhibition efficiency was achieved using lead encapsulated in liposomes at a concentration 100 µM, which is 2.5 times lower. Similarly, application of 29 µM encapsulated lead concentration had the same effect in a 24 h time period as 250 µM in the case of free lead ions. From these results it is obvious that the effect of liposomes is more evident in the long-term evaluation. It is necessary to add the information about the maximum inhibition effect for encapsulated lead which occurs at 250 µM and was about 99% for 6 h and 96% for 24 h.
The statistically calculated IC50 values for evaluating the lead cytotoxicity are summarized in Table 1. Presented values show significant differences between the lead enclosed in liposomes and free lead. The various IC50 values confirm one important. After 24 h the difference between the IC50 values for free and encapsulated lead is so different that this suggestion could be considered as confirmed. Similar results are presented in another related works [31,32,33,34,35].
|Table 1. Calculated values of IC50 (as micro molar concentration of lead) for various times of S. aureus incubation.|
|Hours||Free lead||Encapsulated lead|
Another important obvious trend is visible in the free ion application where the inhibition effect fades with time. An opposite trend is visible in the case of liposome encapsulation. Here the inhibition effect grows with a maximum at 18 h (but the difference at 24 h is small). These two opposite trends confirm, in fact, the basic fact about lead encapsulation because various ways of lead transport into S. aureus cell had to be done. The shorter way of free lead ions and the longer way for the liposome transport into cells. Another important thing is more stable time effect of encapsulated lead compared to free ions. A more stable time effect is necessary to understand in concentration range, as there is a small concentration difference between the various IC50 values during the whole time period (24 h).
3. Experimental Section
3.1. Chemicals and Materials
Cholesterol, 1,2-dioleoyl-sn-glycero-3-phospho-rac-(1-glycerol) sodium salt, chloroform, Pb(NO3)2 and water (for liposome preparation) of ACS purity quality were purchased from Sigma-Aldrich (St. Louis, MO, USA). Hydrogenated phosphatidylcholine from soybeans was a gift from Lipoid GMBH (Ludwigshafen, Germany). To pipette volumes down to micro- and nanolitres, pipettes were purchased from Eppendorf Research (Eppendorf, Hamburg, Germany). The water (for bacterial cultivation) was prepared using Aqual 25 reverse osmosis equipment (Brno, Czech Republic). The water was further purified by using a MiliQ Direct QUV apparatus equipped with the UV lamp (Aqua Osmotic, Tisnov, Czech Republic). The resistance was 18 MΩ. The pH was measured using a WTW inoLab pH meter (Weilheim, Germany).
3.2. Preparation of Liposome
Liposomes were prepared by modification of a published method . Cholesterol (100 mg), 1,2-dioleoyl-sn-glycero-3-phospho-rac-(1-glycerol) sodium salt (100 mg) and phosphatidylcholine (100 mg) were dissolved in chloroform (4.5 mL). A lipid film was obtained by rotary evaporation of solvent and residual chloroform was blown off with nitrogen.
3.3. Preparation of Liposome Filled with Lead
Solutions containing 0, 0.5, 1, 2.5 and 5 mg of lead (in the form of lead nitrate) were added to liposomes (20 mg). Samples were homogenized with an Ultra-Turrax T8 (IKA Werke GMBH, Staufen, Germany) for 10 min. The homogenized mixtures were then heated and shaken for 15 min at 60 °C at Thermomixer Comfort (Eppendorf). The samples were then washed several times with water on Amicon 3k (Millipore, Billerica, MA, USA). Final volume of samples was 1 mL.
3.4. Electrochemical Determination
3.4.1. Differential Pulse Voltammetry (DPV)
Measurement of lead by DPV were performed with a 746 VA Trace analyser connected to a 695 Autosampler (Metrohm, Zofingen, Switzerland), using a standard cell with three electrodes. For data processing the VA Database 2.2 software provided by Metrohm CH was employed. The parameters of the measurement were as follows: initial potential of −1.2 V, end potential 0.15 V, deposition potential −1.2 V, deposition 480 s, deoxygenating with argon 60 s. Dosage was 25 µL of the sample to 1,975 µL of acetate buffer pH = 5.
3.4.2. Cyclic Voltammetry (CV)
Determination of lead by CV were performed with a 797 VA Computrace instrument connected to a 813 Compact Autosampler (Metrohm), using a standard cell with three electrodes. For data processing the 797 VA Computrace software by Metrohm CH was employed. The parameters of the measurement were as follows: initial potential of −1.2 V, first vertex potential 0.15 V, second vertex potential −1.2 V, sweep rate 50–800 mV/s, deposition potential −1.2 V, deposition 480 s, deoxygenation with argon 60 s. Before the measurement 25 µL of the sample was added to the 1,975 µL of 0.2 M acetate buffer pH = 5.
3.5. Atomic Absorption Spectrometry (AAS)
Determination of lead was carried out on an 240FS Agilent Technologies atomic absorption spectrometer (Agilent Technologies, Santa Clara, CA, USA) with flame atomization. The lead hollow cathode lamp (Agilent) was operated at the current of 10 mA. Lead was measured at the wavelength of 217.0 nm with spectral bandwidth of 1.0 nm. The mixture of air and acetylene was used for flame atomization. Deuterium background correction was used and the signal was measured in integration mode for 2 s.
3.6. Toxicity Determination of Free Lead Ions and Lead Encapsulated in the Liposome
3.6.1. Cultivation of Staphylococcus aureus
Staphylococcus aureus (NCTC 8511) was obtained from the Czech Collection of Microorganisms, Faculty of Science, Masaryk University, Brno, Czech Republic. Strains were stored as a spore suspension in 20% (v/v) glycerol at −20 °C. Prior to use in this study, the strains were thawed and the glycerol was removed by washing with distilled water. The composition of cultivation medium was as follows: 10 g tryptone, 5 g yeast extract and 5 g NaCl/L MilliQ water (Duchefa Biochemie, Haarlem, The Netherlands).The pH of the cultivation medium was adjusted at 7.4 before sterilization. Sterilization of media was carried out at 121°C for 30 min in a Tuttnauer 2450EL sterilizer (Tuttauer, Breda, The Netherlands). The prepared cultivation media were inoculated with bacterial culture in 25 mL Erlenmeyer flasks. After inoculation, bacterial cultures were cultivated for 24 h on a shaker at 600 rpm and 37 °C. Bacterial culture cultivated under these conditions [37,38] was diluted by cultivation medium to OD600 = 0.1 and used in the following experiments.
3.6.2. Growth Curves
The procedure for the evaluation of the antimicrobial effect of the tested compounds involved measuring the absorbance using a Multiskan EX apparatus (Thermo Fisher Scientific, Waltham, MA, USA) and subsequent analysis in the form of growth curves [39,40]. The 24 h grown culture of S. aureus was diluted with LB medium (10 g tryptone, 5 g yeast extract, 5 g NaCl/L deionised water) using a Specord 210 spectrophotometer (Analytik Jena, Jena, Germany) at wavelength of 600 nm to absorbance 0.1. In the microplate S. aureus culture was mixed with various concentrations of lead in or without liposomes in different concentrations or S. aureus alone as a control for measurements. The concentrations of lead were 5, 10, 20, 50, 100, 150, 200 and 250 μM. Total volume in the microplate wells was 300 µL. Measurements were carried out at time 0, and every 30 min for 24 h at 37 °C at the wavelength of 620 nm. The values achieved were individually analysed in graphic form as growth curves for each group.
3.6.3. Statistical Evaluation
The software STATISTICA (data analysis software system), version 10.0 (StatSoft, Tulsa, OK, USA) was used for data processing. Half-maximal concentrations (IC50) were calculated from logarithmic regression of sigmoideal dose-response curves. A general regression model was used to analyse differences between the combinations of compounds. To reveal differences between cell lines, Turkey’s post hoc test within homogenous groups was employed. Unless noted otherwise, p < 0.05 was considered significant.
3.6.4. Cell Microscopy
An inverted system microscope Olympus IX 71 (Tokyo, Japan) was used for imaging the cells. The cells in cultivation medium were pipetted (5 μL) onto a microscope slide and covered by a cover slip. The sample was placed cover slip down and the immersion oil was used. The objective (PlanFLN; Mag. 100×; NA 1.3; F.N. 26.5) and the magnification lens 1.6× were used; the total magnification was 1,600×. The images were captured by an Olympus DP73 camera and processed by the Stream Basic 1.7 Software. The image resolution was 4,800 × 3,600 pixels. The parameters were as follows: exposure time: 32 ms and ISO 200.
Liposomes appear to be a suitable carrier of various substances due to their inner cavity. This ability makes liposomes among the most researched organic nanoparticles. The lead encapsulation into the liposome structure and the influence of the liposome matrix on the electrochemical detection of lead was confirmed. Lead encapsulated in the liposomes is more easily accessible to the cells of S. aureus and its toxicity in comparison with free lead ions is higher. In addition, we have demonstrated that electrochemical methods could be very suitable tools for the determination of electroactive compounds enclosed in liposomes.
Financial support by CEITEC CZ.1.05/1.1.00/02.0068 is highly acknowledged.
Conflicts of Interest
The authors declare no conflict of interest.
- Neal, A.P.; Guilarte, T.R. Mechanisms of lead and manganese neurotoxicity. Toxicol. Res. 2013, 2, 99–114, doi:10.1039/c2tx20064c.
- Afridi, H.I.; Kazi, T.G.; Arain, M.B.; Jamali, M.K.; Kazi, G.H.; Jalbani, N. Determination of cadmium and lead in biological samples by three ultrasonic-based samples treatment procedures followed by electrothermal atomic absorption spectrometry. J. AOAC Int. 2007, 90, 470–478.
- Najafi, N.M.; Massumi, A.; Shafaghizadeh, M. In situ digestion of serum samples in graphite furnace prior to determination by ETAAS. Sci. Iran. 2005, 12, 324–328.
- Afridi, H.I.; Kazi, T.G.; Kazi, A.G.; Shah, F.; Wadhwa, S.K.; Kolachi, N.F.; Shah, A.Q.; Baig, J.A.; Kazi, N. Levels of arsenic, cadmium, lead, manganese and zinc in biological samples of paralysed steel mill workers with related to controls. Biol. Trace Elem. Res. 2011, 144, 164–182, doi:10.1007/s12011-011-9063-4.
- Parsons, P.J. Monitoring human exposure to lead—An assessment of current laboratory performance for the determination of blood lead. Environ. Res. 1992, 57, 149–162, doi:10.1016/S0013-9351(05)80075-1.
- Blazewicz, A.; Orlicz-Szczesna, G.; Prystupa, A.; Szczesny, P. Use of ion chromatography for the determination of selected metals in blood serum of patients with type 2 diabetes. J. Trace Elem. Med. Biol. 2010, 24, 14–26, doi:10.1016/j.jtemb.2009.08.001.
- Vamvakaki, V.; Fournier, D.; Chaniotakis, N.A. Fluorescence detection of enzymatic activity within a liposome based nano-biosensor. Biosens. Bioelectron. 2005, 21, 384–388, doi:10.1016/j.bios.2004.10.028.
- Livney, Y.D. Milk proteins as vehicles for bioactives. Curr. Opin. Colloid Interface Sci. 2010, 15, 73–83, doi:10.1016/j.cocis.2009.11.002.
- Pantos, A.; Tsiourvas, D.; Paleos, C.M.; Nounesis, G. Enhanced drug transport from unilamellar to multilamellar liposomes induced by molecular recognition of their lipid membranes. Langmuir 2005, 21, 6696–6702, doi:10.1021/la050211n.
- Sharma, A.; Sharma, U.S. Liposomes in drug delivery: Progress and limitations. Int. J. Pharm. 1997, 154, 123–140, doi:10.1016/S0378-5173(97)00135-X.
- Dos Santos, N.; Waterhouse, D.; Masin, D.; Tardi, P.G.; Karlsson, G.; Edwards, K.; Bally, M.B. Substantial increases in idarubicin plasma concentration by liposome encapsulation mediates improved antitumor activity. J. Control. Release 2005, 105, 89–105, doi:10.1016/j.jconrel.2005.03.007.
- Oja, C.; Tardi, P.; Schutze-Redelmeier, M.P.; Cullis, P.R. Doxorubicin entrapped within liposome-associated antigens results in a selective inhibition of the antibody response to the linked antigen. Biochim. Biophys. Acta-Biomembr. 2000, 1468, 31–40, doi:10.1016/S0005-2736(00)00178-4.
- Petersen, A.L.; Hansen, A.E.; Gabizon, A.; Andresen, T.L. Liposome imaging agents in personalized medicine. Adv. Drug Deliv. Rev. 2012, 64, 1417–1435, doi:10.1016/j.addr.2012.09.003.
- Viswanathan, S.; Wu, L.C.; Huang, M.R.; Ho, J.A.A. Electrochemical immunosensor for cholera toxin using liposomes and poly(3,4-ethylenedioxythiophene)-coated carbon nanotubes. Anal. Chem. 2006, 78, 1115–1121, doi:10.1021/ac051435d.
- Zhong, Z.Y.; Peng, N.; Qing, Y.; Shan, J.L.; Li, M.X.; Guan, W.; Dai, N.; Gu, X.Q.; Wang, D. An electrochemical immunosensor for simultaneous multiplexed detection of neuron-specific enolase and pro-gastrin-releasing peptide using liposomes as enhancer. Electrochim. Acta 2011, 56, 5624–5629.
- Drbohlavova, J.; Adam, V.; Kizek, R.; Hubalek, J. Quantum dots—Characterization, preparation and usage in biological systems. Int. J. Mol. Sci. 2009, 10, 656–673, doi:10.3390/ijms10020656.
- Hynek, D.; Prasek, J.; Pikula, J.; Adam, V.; Hajkova, P.; Krejcova, L.; Trnkova, L.; Sochor, J.; Pohanka, M.; Hubalek, J.; et al. Electrochemical analysis of lead toxicosis in vultures. Int. J. Electrochem. Sci. 2011, 6, 5980–6010.
- Krystofova, O.; Trnkova, L.; Adam, V.; Zehnalek, J.; Hubalek, J.; Babula, P.; Kizek, R. Electrochemical microsensors for the detection of cadmium(II) and lead(II) ions in plants. Sensors 2010, 10, 5308–5328, doi:10.3390/s100605308.
- Hynek, D.; Krejcova, L.; Krizkova, S.; Ruttkay-Nedecky, B.; Pikula, J.; Adam, V.; Hajkova, P.; Trnkova, L.; Sochor, J.; Pohanka, M.; et al. Metallomics study of lead-protein interactions in albumen by electrochemical and electrophoretic methods. Int. J. Electrochem. Sci. 2012, 7, 943–964.
- Krizkova, S.; Zitka, O.; Adam, V.; Beklova, M.; Horna, A.; Svobodova, Z.; Sures, B.; Trnkova, L.; Zeman, L.; Kizek, R. Possibilities of electrochemical techniques in metallothionein and lead detection in fish tissues. Czech J. Anim. Sci. 2007, 52, 143–148.
- Sochor, J.; Majzlik, P.; Salas, P.; Adam, V.; Trnkova, L.; Hubalek, J.; Kizek, R. A study of availability of heavy metal ions by using various exracction procedures and electrochemical detection. Lis. Cukrov. Repar. 2010, 126, 414–415.
- Percival, S.L.; Thomas, J.; Linton, S.; Okel, T.; Corum, L.; Slone, W. The antimicrobial efficacy of silver on antibiotic-resistant bacteria isolated from burn wounds. Int. Wound J. 2012, 9, 488–493, doi:10.1111/j.1742-481X.2011.00903.x.
- Martinez-Abad, A.; Sanchez, G.; Lagaron, J.M.; Ocio, M.J. On the different growth conditions affecting silver antimicrobial efficacy on Listeria monocytogenes and Salmonella enterica. Int. J. Food Microbiol. 2012, 158, 147–154, doi:10.1016/j.ijfoodmicro.2012.07.010.
- Fernandez-Saiz, P.; Soler, C.; Lagaron, J.M.; Ocio, M.J. Effects of chitosan films on the growth of Listeria monocytogenes, Staphylococcus aureus and Salmonella spp. in laboratory media and in fish soup. Int. J. Food Microbiol. 2010, 137, 287–294, doi:10.1016/j.ijfoodmicro.2009.11.016.
- Borneman, D.L.; Ingham, S.C.; Ane, C. Mathematical approaches to estimating lag-phase duration and growth rate for predicting growth of Salmonella serovars, Escherichia coli O157:H7, and Staphylococcus aureus in raw beef, bratwurst, and poultry. J. Food Prot. 2009, 72, 1190–1200.
- Rufian-Henares, J.A.; Morales, F.J. Microtiter plate-based assay for screening antimicrobial activity of melanoidins against E. coli and S. aureus. Food Chem. 2008, 111, 1069–1074, doi:10.1016/j.foodchem.2008.05.027.
- Mahdavi, B.; Yaacob, W.A.; Din, L.B.; Nazlina, I. Antimicrobial activity of consecutive extracts of Etlingera brevilabrum. Sains Malays. 2012, 41, 1233–1237.
- Jenkins, R.; Burton, N.; Cooper, R. Manuka honey inhibits cell division in methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 2011, 66, 2536–2542, doi:10.1093/jac/dkr340.
- Belley, A.; Harris, R.; Beveridge, T.; Parr, T.; Moeck, G. Ultrastructural effects of oritavancin on methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. Antimicrob. Agents Chemother. 2009, 53, 800–804, doi:10.1128/AAC.00603-08.
- Webster, D.; Rennie, R.P.; Brosnikoff, C.L.; Chui, L.; Brown, C. Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Canada. Diagn. Microbiol. Infect. Dis. 2007, 57, 177–181, doi:10.1016/j.diagmicrobio.2006.07.007.
- Haferburg, G.; Kothe, E. Microbes and metals: Interactions in the environment. J. Basic Microbiol. 2007, 47, 453–467, doi:10.1002/jobm.200700275.
- Huang, C.M.; Chen, C.H.; Pornpattananangkul, D.; Zhang, L.; Chan, M.; Hsieh, M.F.; Zhang, L.F. Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids. Biomaterials 2011, 32, 214–221.
- Kilian, G.; Tshanga, S.S.; Oidu, B.; Milne, P.J. Antimicrobial activity of liposome encapsulated cyclo(l-tyrosyl-l-prolyl). Pharmazie 2011, 66, 421–423.
- Low, W.L.; Martin, C.; Hill, D.J.; Kenward, M.A. Antimicrobial efficacy of liposome-encapsulated silver ions and tea tree oil against Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans. Lett. Appl. Microbiol. 2013, 57, 33–39, doi:10.1111/lam.12082.
- Omri, A.; Ravaoarinoro, M. Preparation, properties and the effects of amikacin, netilmicin and tobramycin in free and liposomal formulations on Gram-negative and Gram-positive bacteria. Int. J. Antimicrob. Agents 1996, 7, 9–14, doi:10.1016/0924-8579(96)00003-9.
- Kunjachan, S.; Blauz, A.; Mockel, D.; Theek, B.; Kiessling, F.; Etrych, T.; Ulbrich, K.; van Bloois, L.; Storm, G.; Bartosz, G.; et al. Overcoming cellular multidrug resistance using classical nanomedicine formulations. Eur. J. Pharm. Sci. 2012, 45, 421–428, doi:10.1016/j.ejps.2011.08.028.
- Gonzalez, N.; Sevillano, D.; Alou, L.; Cafini, F.; Gimenez, M.-J.; Gomez-Lus, M.-L.; Prieto, J.; Aguilar, L. Influence of the MBC/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum and soft tissue interstitial fluid concentrations reported in diabetic patients. J. Antimicrob. Chemother. 2013, 68, 2291–2295.
- Chudobova, D.; Dobes, J.; Nejdl, L.; Maskova, D.; Rodrigo, M.A.M.; Nedecky, B.R.; Krystofova, O.; Kynicky, J.; Konecna, M.; Pohanka, M.; et al. Oxidative stress in Staphylococcus aureus treated with silver(I) ions revealed by spectrometric and voltammetric assays. Int. J. Electrochem. Sci. 2013, 8, 4422–4440.
- Gangwar, A. Antimicrobial effectiveness of different preparations of calcium hydroxide. Ind. J. Dental Res. 2011, 22, 66–70, doi:10.4103/0970-9290.79986.
- Chudobova, D.; Nejdl, L.; Gumulec, J.; Krystofova, O.; Rodrigo, M.A.M.; Kynicky, J.; Ruttkay-Nedecky, B.; Kopel, P.; Babula, P.; Adam, V.; et al. Complexes of silver(I) ions and silver phosphate nanoparticles with hyaluronic acid and/or chitosan as promising antimicrobial agents for vascular grafts. Int. J. Mol. Sci. 2013, 14, 13592–13614.
© 2013 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).